These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 30584302)

  • 1. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
    Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug.
    Nosrati H; Sefidi N; Sharafi A; Danafar H; Kheiri Manjili H
    Bioorg Chem; 2018 Feb; 76():501-509. PubMed ID: 29310081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Intestinal Absorption Mechanism and Pharmacokinetics of Curcumin-Loaded Galactosylated Albumin Nanoparticles.
    Huang Y; Deng S; Luo X; Liu Y; Xu W; Pan J; Wang M; Xia Z
    Int J Nanomedicine; 2019; 14():9721-9730. PubMed ID: 31849464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin delivery.
    Salehiabar M; Nosrati H; Javani E; Aliakbarzadeh F; Kheiri Manjili H; Davaran S; Danafar H
    Int J Biol Macromol; 2018 Aug; 115():83-89. PubMed ID: 29653171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of curcumin-loaded galactosylated chitosan-coated nanoparticles for targeted delivery of hepatocellular carcinoma.
    Huang M; Liu J; Fan Y; Sun J; Cheng JX; Zhang XF; Zhai BT; Guo DY
    Int J Biol Macromol; 2023 Dec; 253(Pt 6):127219. PubMed ID: 37802456
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sun R; Fang L; Lv X; Fang J; Wang Y; Chen D; Wang L; Chen J; Qi Y; Tang Z; Zhang J; Tian Y
    Drug Deliv; 2021 Dec; 28(1):2071-2084. PubMed ID: 34595970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
    Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y
    Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BSA Nanoparticles Modified with
    Zhang S; Asghar S; Yu F; Chen Z; Hu Z; Ping Q; Shao F; Xiao Y
    J Agric Food Chem; 2019 Aug; 67(33):9371-9381. PubMed ID: 31379162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
    Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
    Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer.
    Zhao X; Chen Q; Liu W; Li Y; Tang H; Liu X; Yang X
    Int J Nanomedicine; 2015; 10():257-70. PubMed ID: 25565818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactosylated alginate-curcumin micelles for enhanced delivery of curcumin to hepatocytes.
    Sarika PR; James NR; Kumar PR; Raj DK
    Int J Biol Macromol; 2016 May; 86():1-9. PubMed ID: 26774374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactosylated Albumin Nanoparticles: Potential Drug Nanovehicles with Selective Targeting Toward an In Vitro Model of Hepatocellular Carcinoma.
    Teran-Saavedra NG; Sarabia-Sainz JA; Silva-Campa E; Burgara-Estrella AJ; Guzmán-Partida AM; Ramos-Clamont Montfort G; Pedroza-Montero M; Vazquez-Moreno L
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30970533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatibility and potential anticancer activity of gadolinium oxide (Gd
    Sun X; Kou B
    BMC Biotechnol; 2024 Aug; 24(1):53. PubMed ID: 39107760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles.
    Bian Y; Guo D
    Drug Des Devel Ther; 2020; 14():647-659. PubMed ID: 32109990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactosylated chitosan-polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin.
    Zhou N; Zan X; Wang Z; Wu H; Yin D; Liao C; Wan Y
    Carbohydr Polym; 2013 Apr; 94(1):420-9. PubMed ID: 23544558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin-Loaded Hybrid Nanoparticles: Microchannel-Based Preparation and Antitumor Activity in a Mouse Model.
    Hong W; Gao Y; Lou B; Ying S; Wu W; Ji X; Yu N; Jiao Y; Wang H; Zhou X; Li A; Guo F; Yang G
    Int J Nanomedicine; 2021; 16():4147-4159. PubMed ID: 34168445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionalizing the surface of hydroxyapatite drug carrier with carboxylic acid groups to modulate the loading and release of curcumin nanoparticles.
    Lee WH; Loo CY; Rohanizadeh R
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():929-939. PubMed ID: 30889767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(lactic-
    Kumar P; Singh AK; Raj V; Rai A; Keshari AK; Kumar D; Maity B; Prakash A; Maiti S; Saha S
    Int J Nanomedicine; 2018; 13():975-990. PubMed ID: 29497292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.